Geriatric Oncology: A Multidisciplinary Approach in a Global Environment
Lina Silva Salinas2021-07-29T22:37:57+02:00Gouri Shankar Bhattacharyya, MD, and Stuart M. Lichtman, MD, The ASCO Post, June 10, 2017
Pioneer in Geriatric Oncology, Hyman Muss, MD, Continues to Improve Care for Older Patients
Lina Silva Salinas2021-07-29T22:37:57+02:00by The ASCO Post - June 03, 2017
Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations
Lina Silva Salinas2021-08-05T08:16:48+02:00Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, Coolbrandt A, Biganzoli L. Cancer Treat Rev. 2017 Jun;57:58-66. doi: 10.1016/j.ctrv.2017.05.002. Epub 2017 May 15.
Frailty Research into the Medical Specialties-Report from a U13 Conference
Lina Silva Salinas2021-07-29T22:37:57+02:00Walston J, Robinson TN, Zieman S, McFarland F, Carpenter CR, Althoff KN, Andrew MK, Blaum CS, Brown PJ, Buta B, Ely EW, Ferrucci L, High KP, Kritchevsky SB, Rockwood K, Schmader KE, Sierra F, Sink KM, Varadhan R, Hurria A. J Am Geriatr Soc. 2017 Apr 19. doi: 10.1111/jgs.14902. [Epub ahead of print] Integrating
Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older
Lina Silva Salinas2021-07-29T22:37:57+02:00Battisti NML, Sehovic M, Extermann M. Clin Lung Cancer. 2017 Mar 21. pii: S1525-7304(17)30082-7. doi: 10.1016/j.cllc.2017.03.005. [Epub ahead of print]
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
Lina Silva Salinas2021-07-29T22:37:57+02:00Visco C, Chiappella A, Nassi L, Patti C, Ferrero S, Barbero D, Evangelista A, Spina M, Molinari A, Rigacci L, Tani M, Rocco AD, Pinotti G, Fabbri A, Zambello R, Finotto S, Gotti M, Carella AM, Salvi F, Pileri SA, Ladetto M, Ciccone G, Gaidano G, Ruggeri M, Martelli M, Vitolo U. Lancet Haematol. 2017 Jan;4(1):e15-e23. doi: 10.1016/S2352-3026(16)30185-5. Epub 2016 Dec 5.
Biosimilars and cancer treatment of older patients
Lina Silva Salinas2021-07-29T22:37:57+02:00Lichtman SM, Reske T, Jacobs IA. J Geriatr Oncol. 2016 Mar;7(1 Suppl):S1-8. doi: 10.1016/j.jgo.2016.01.002. Epub 2016 Feb 5.
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
Lina Silva Salinas2021-07-29T22:37:57+02:00Kraeber-Bodere F, Pallardy A, Maisonneuve H, Campion L, Moreau A, Soubeyran I, Le Gouill S, Tournilhac O, Daguindau E, Jardel H, Morineau N, Bouabdallah K, Gyan E, Moles MP, Gressin R, Berthou C, Sadot S, Moreau P, Deau B, Bodet-Milin C, Cazeau AL, Garin E, Salaun PY, Vuillez JP, Gouilleux-Gruart V, Barbet J, Wegener WA, Goldenberg DM, Lamy T, Soubeyran P. Lancet Haematol. 2017 Jan;4(1):e35-e45. doi: 10.1016/S2352-3026(16)30168-5. Epub 2016 Dec 8.
Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States
Lina Silva Salinas2021-07-29T22:37:57+02:00Fang P, He W, Gomez DR, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Int J Radiat Oncol Biol Phys. 2017 Feb 1. pii: S0360-3016(17)30291-2. doi: 10.1016/j.ijrobp.2017.01.228. [Epub ahead of print]
Chirec Cancer Institute (CCI)
Lina Silva Salinas2025-06-12T19:29:22+02:00Program Opportunities Involvement in any clinical activity: Clinical board and outpatient clinics; observership Availability of any funding supporting any trainee/researcher: Not available Duration of program: According to previous agreement, minimum 1 month Application process: Send a CV and letter of interest to the contact person Accepts international trainees: Yes Contact person: lissandra.dallago@chirec.be Website: https://www.chirec.be/fr/centre_parent/chirec-cancer-institute-cci Â
